{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T22:46:02Z","timestamp":1794955562371,"version":"4.9.1"},"reference-count":37,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["bbmt.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biology of Blood and Marrow Transplantation"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1016\/j.bbmt.2017.04.002","type":"journal-article","created":{"date-parts":[[2017,4,7]],"date-time":"2017-04-07T18:15:44Z","timestamp":1491588944000},"page":"1110-1116","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":53,"title":["Dose Escalation of Total Marrow Irradiation in High-Risk Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation"],"prefix":"10.1016","volume":"23","author":[{"given":"Susanta","family":"Hui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Brunstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutaka","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todd","family":"DeFor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shernan G.","family":"Holtan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronika","family":"Bachanova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Wilke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darren","family":"Zuro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celalettin","family":"Ustun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Weisdorf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn","family":"Dusenbery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7097-5917","authenticated-orcid":false,"given":"Michael R.","family":"Verneris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbmt.2017.04.002_bib0010","doi-asserted-by":"crossref","first-page":"3730","DOI":"10.1200\/JCO.2010.28.8852","article-title":"Hematopoietic stem-cell transplantation for acute leukemia in relapse or primary induction failure","volume":"28","author":"Duval","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2017.04.002_bib0015","doi-asserted-by":"crossref","first-page":"3501","DOI":"10.1182\/blood-2014-12-615757","article-title":"IgH-V(D)J NGS-MRD measurement pre- and early post-allotransplant defines very low- and very high-risk ALL patients","volume":"125","author":"Pulsipher","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2017.04.002_bib0020","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1182\/blood-2013-06-506725","article-title":"Significance of minimal residual disease before myeloablative allogeneic hematopoietic cell transplantation for AML in first and second complete remission","volume":"122","author":"Walter","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2017.04.002_bib0025","article-title":"Allogeneic transplantation for advanced AML: the value of complete remission","author":"Weisdorf","year":"2016","journal-title":"Cancer"},{"key":"10.1016\/j.bbmt.2017.04.002_bib0030","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1259\/bjr.70.840.9505837","article-title":"The radiobiological basis of total body irradiation","volume":"70","author":"Wheldon","year":"1997","journal-title":"Br J Radiol"},{"key":"10.1016\/j.bbmt.2017.04.002_bib0035","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1007\/s00066-006-1528-6","article-title":"Biologically effective dose in total-body irradiation and hematopoietic stem cell transplantation","volume":"182","author":"Kal","year":"2006","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.bbmt.2017.04.002_bib0040","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.bbmt.2005.12.029","article-title":"A comparison of cyclophosphamide and total body irradiation with etoposide and total body irradiation as conditioning regimens for patients undergoing sibling allografting for acute lymphoblastic leukemia in first or second complete remission","volume":"12","author":"Marks","year":"2006","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2017.04.002_bib0045","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1182\/blood.V76.9.1867.1867","article-title":"Allogeneic marrow transplantation in patients with acute myeloid leukemia in first remission: a randomized trial of two irradiation regimens","volume":"76","author":"Clift","year":"1990","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2017.04.002_bib0050","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1182\/blood.V77.8.1660.1660","article-title":"Allogeneic marrow transplantation in patients with chronic myeloid leukemia in the chronic phase: a randomized trial of two irradiation regimens","volume":"77","author":"Clift","year":"1991","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2017.04.002_bib0055","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1182\/blood.V92.4.1455","article-title":"Long-term follow-up of a randomized trial of two irradiation regimens for patients receiving allogeneic marrow transplants during first remission of acute myeloid leukemia","volume":"92","author":"Clift","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2017.04.002_bib0060","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0360-3016(96)85011-5","article-title":"Cataractogenesis after total body irradiation","volume":"35","author":"Belkac\u00e9mi","year":"1996","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.bbmt.2017.04.002_bib0065","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/0360-3016(94)00428-N","article-title":"Clinical radiation nephropathy","volume":"31","author":"Cassady","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.bbmt.2017.04.002_bib0070","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1016\/0360-3016(81)90032-8","article-title":"Idiopathic interstitial pneumonia following bone marrow transplantation: the relationship with total body irradiation","volume":"7","author":"Keane","year":"1981","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.bbmt.2017.04.002_bib0075","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/sj.bmt.1703133","article-title":"Serious cardiac complications during bone marrow transplantation at the University of Minnesota, 1977-1997","volume":"28","author":"Murdych","year":"2001","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2017.04.002_bib0170","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1748-717X-9-34","article-title":"Fast, simple, and informative patient-specific dose verification method for intensity modulated total marrow irradiation with helical tomotherapy","volume":"9","author":"Takahashi","year":"2014","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.bbmt.2017.04.002_bib0080","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1080\/02841860601042449","article-title":"Helical tomotherapy targeting total bone marrow\u2015first clinical experience at the University of Minnesota","volume":"46","author":"Hui","year":"2007","journal-title":"Acta Oncol (Madr)"},{"key":"10.1016\/j.bbmt.2017.04.002_bib0085","doi-asserted-by":"crossref","first-page":"3214","DOI":"10.1118\/1.2044428","article-title":"Feasibility study of helical tomotherapy for total body or total marrow irradiation","volume":"32","author":"Hui","year":"2005","journal-title":"Med Phys"},{"key":"10.1016\/j.bbmt.2017.04.002_bib0090","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.ijrobp.2013.07.017","article-title":"Peripheral dose heterogeneity due to the thread effect in total marrow irradiation with helical tomotherapy","volume":"87","author":"Takahashi","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.bbmt.2017.04.002_bib0095","doi-asserted-by":"crossref","first-page":"3545","DOI":"10.1088\/0031-9155\/45\/12\/303","article-title":"Megavoltage CT image reconstruction during tomotherapy treatments","volume":"45","author":"Ruchala","year":"2000","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.bbmt.2017.04.002_bib0100","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1177\/153303460900800104","article-title":"Multimodality image guided total marrow irradiation and verification of the dose delivered to the lung, PTV, and thoracic bone in a patient: a case study","volume":"8","author":"Hui","year":"2009","journal-title":"Technol Cancer Res Treat"},{"key":"10.1016\/j.bbmt.2017.04.002_bib0105","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1007\/s00066-011-0066-z","article-title":"Three-dimensional patient setup errors at different treatment sites measured by the tomotherapy megavoltage CT","volume":"188","author":"Hui","year":"2012","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.bbmt.2017.04.002_bib0110","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1259\/0007-1285-62-740-679","article-title":"The linear-quadratic formula and progress in fractionated radiotherapy","volume":"62","author":"Fowler","year":"1989","journal-title":"Br J Radiol"},{"key":"10.1016\/j.bbmt.2017.04.002_bib0115","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/0360-3016(94)90320-4","article-title":"Radiobiological features of acute myeloblastic leukemia: comparison of self-renewal versus terminally differentiated populations","volume":"30","author":"Cowen","year":"1994","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.bbmt.2017.04.002_bib0120","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1002\/sim.4780141102","article-title":"Some practical improvements in the continual reassessment method for phase I studies","volume":"14","author":"Goodman","year":"1995","journal-title":"Stat Med"},{"key":"10.1016\/j.bbmt.2017.04.002_bib0125","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Nonparametric estimation from incomplete observations","volume":"53","author":"Kaplan","year":"1958","journal-title":"J Am Stat Assoc"},{"key":"10.1016\/j.bbmt.2017.04.002_bib0130","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1002\/(SICI)1097-0258(19970430)16:8<901::AID-SIM543>3.0.CO;2-M","article-title":"Non-parametric inference for cumulative incidence functions in competing risks studies","volume":"16","author":"Lin","year":"1997","journal-title":"Stat Med"},{"key":"10.1016\/j.bbmt.2017.04.002_bib0135","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1182\/blood-2008-07-163238","article-title":"Acute graft-versus-host disease after unrelated donor umbilical cord blood transplantation: analysis of risk factors","volume":"113","author":"MacMillan","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2017.04.002_bib0140","doi-asserted-by":"crossref","first-page":"4293","DOI":"10.1182\/blood-2009-05-220525","article-title":"Relapse risk after umbilical cord blood transplantation: enhanced graft-versus-leukemia effect in recipients of 2 units","volume":"114","author":"Verneris","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2017.04.002_bib0145","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1056\/NEJMoa1405584","article-title":"One-unit versus two-unit cord-blood transplantation for hematologic cancers","volume":"371","author":"Wagner","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bbmt.2017.04.002_bib0150","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.radonc.2011.01.016","article-title":"Helical tomotherapy targeting total bone marrow after total body irradiation for patients with relapsed acute leukemia undergoing an allogeneic stem cell transplant","volume":"98","author":"Corv\u00f2","year":"2011","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.bbmt.2017.04.002_bib0155","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.bbmt.2017.01.067","article-title":"Phase I trial of total marrow and lymphoid irradiation transplant conditioning in patients with relapsed\/refractory acute leukemia","volume":"23","author":"Stein","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2017.04.002_bib0160","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1016\/j.bbmt.2014.09.005","article-title":"Combination of linear accelerator-based intensity-modulated total marrow irradiation and myeloablative fludarabine\/busulfan: a phase I study","volume":"20","author":"Patel","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2017.04.002_bib0165","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/S0360-3016(01)02664-5","article-title":"Direct evidence that prostate tumors show high sensitivity to fractionation (low alpha\/beta ratio), similar to late-responding normal tissue","volume":"52","author":"Brenner","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.bbmt.2017.04.002_bib0175","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.ijrobp.2016.06.2458","article-title":"Fast megavoltage computed tomography: a rapid imaging method for total body or marrow irradiation in helical tomotherapy","volume":"96","author":"Magome","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.bbmt.2017.04.002_bib0180","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.ijrobp.2014.09.014","article-title":"Multi-institutional feasibility study of a fast patient localization method in total marrow irradiation with helical tomotherapy: a global health initiative by the international consortium of total marrow irradiation","volume":"91","author":"Takahashi","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.bbmt.2017.04.002_bib0185","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.radonc.2015.11.012","article-title":"Marrow damage and hematopoietic recovery following allogeneic bone marrow transplantation for acute leukemias: effect of radiation dose and conditioning regimen","volume":"118","author":"Wilke","year":"2016","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.bbmt.2017.04.002_bib0190","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0073745","article-title":"Effect of radiation dose-rate on hematopoietic cell engraftment in adult zebrafish","volume":"8","author":"Glass","year":"2013","journal-title":"PLoS ONE"}],"container-title":["Biology of Blood and Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879117303907?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879117303907?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:57:32Z","timestamp":1761058652000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1083879117303907"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":37,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["S1083879117303907"],"URL":"https:\/\/doi.org\/10.1016\/j.bbmt.2017.04.002","relation":{},"ISSN":["1083-8791"],"issn-type":[{"value":"1083-8791","type":"print"}],"subject":[],"published":{"date-parts":[[2017,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dose Escalation of Total Marrow Irradiation in High-Risk Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation","name":"articletitle","label":"Article Title"},{"value":"Biology of Blood and Marrow Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbmt.2017.04.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 American Society for Blood and Marrow Transplantation.","name":"copyright","label":"Copyright"}]}}